Please do not leave this page until complete. This can take a few moments.
Opioid deaths showed an 8-percent year-over-year decline between 2016 and 2017, the Massachusetts Department of Public Health (DPH) announced in a quarterly report Wednesday. It is the first time a yearly decline has been reported since 2010, according to state data.
There were 1,977 confirmed opioid-related deaths in 2017, down 8.3 percent from the 2,155 cases confirmed in 2016, according to DPH. This followed six years of double digit increases, with the number of confirmed deaths climbing 22 percent between 2015 and 2016, 30 percent between 2014 and 2015, and 39 percent between 2013 and 2014.
The downward trend follows a number of aggressive initiatives by the Gov. Charlie Baker Administration to reduce the amount of opioids being prescribed for pain management, and to help people struggling with addiction.
In November, Baker proposed a bill to lawmakers, called the CARE Act, which seeks to increase access to treatment, bolster education and prevention efforts, and to take advantage of federal regulatory relief that could help increase treatment access. The proposal, which lawmakers are vetting, builds on the 2016 legislation Baker signed that put a seven-day limit – the first in the nation – on initial opioid prescriptions, as well as revamped the state’s prescription monitoring system and upped penalties for fentanyl trafficking.
``While there is still a lot of work to do, this report is encouraging news that gives us hope that we are beginning to bend the curve of this epidemic,’’ Gov. Charlie Baker said in a statement Wednesday.
Baker highlighted the continued threat posed by fentanyl, a very powerful opioid continuing to cause an increasing number of deaths, according to the latest DPH report. Fentynal was present in toxicology results of 83 percent of confirmed 2017 opioid deaths, the agency said, and the percentage has increased while the presence of heroin declined in 2015 and 2016 and stabilized in 2017.
“I urge the legislature to pass our CARE Act, which expands access to treatment and ask lawmakers to take swift action on legislation to crack down on the fentanyl trade. The data makes clear that we must give law enforcement every possible chance to track down this terrible drug and hold accountable those who sell it,” Baker said.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments